Clinical and methodologic considerations with regard to a trial of nintedanib in patients with systemic sclerosis-associated interstitial lung disease: comment on the reanalysis by Maher et al

被引：1
|
作者：
Bredemeier, Markus [1 ]
机构：
[1] Hosp Nossa Senhora Conceicao, Conceicao Hosp Grp, Porto Alegre, RS, Brazil
来源：
ARTHRITIS & RHEUMATOLOGY | 2021年
关键词：
D O I：
10.1002/art.41893
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Epidemiology of systemic sclerosis and systemic sclerosis-associated interstitial lung disease
    Bergamasco, Aurore
    Hartmann, Nadine
    Wallace, Laura
    Verpillat, Patrice
    CLINICAL EPIDEMIOLOGY, 2019, 11 : 257 - 273
  • [32] Response to: 'Correspondence on 'Safety and tolerability of nintedanib in patients with systemic sclerosis-associated interstitial lung disease: data from the SENSCIS trial'' by Bredemeier
    Seibold, James R.
    Kohlbrenner, Veronika
    Alves, Margarida
    Distler, Oliver
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 (12)
  • [33] Risk of Malnutrition in Patients With Systemic Sclerosis-Associated Interstitial Lung Disease Treated With Nintedanib in the Randomized, Placebo-Controlled SENSCIS Trial
    Volkmann, Elizabeth H.
    McMahan, Zsuzsanna
    Smith, Vanessa
    Jouneau, Stephane
    Miede, Corinna
    Alves, Margarida L.
    Herrick, Ariane
    ARTHRITIS CARE & RESEARCH, 2023, 75 (12) : 2501 - 2507
  • [34] Safety and Tolerability of Nintedanib in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease in the SENSCIS Trial: Subgroup Analysis Based on Demographic Characteristics
    Distler, Oliver
    Highland, Kristin
    Mayes, Maureen
    Kuwana, Masataka
    Saketkoo, Lesley
    Vonk, Madelon
    Kreuter, Michael
    Hummers, Laura
    von Wangenheim, Ute
    Gahlemann, Martina
    Kohlbrenner, Veronika
    Alves, Margarida
    Clerisme-Beaty, Emmanuelle
    Azuma, Arata
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [35] NOCEBO EFFECT ON DIARRHOEA REPORTED IN THE SENSCIS TRIAL OF NINTEDANIB IN PATIENTS WITH SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE (SSC-ILD)
    Distler, O.
    Highland, K.
    Azuma, A.
    Miede, C.
    Alves, M.
    Sfikakis, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1457 - 1457
  • [36] Nintedanib in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD) and Organ Damage: Data from the SENSCIS Trial
    Pope, Janet
    Proudman, Susanna
    Stevens, Wendy
    Henes, Joerg
    Simonovska, Rozeta
    Alves, Margarida
    Allanore, Yannick
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 3025 - 3027
  • [37] Efficacy and Safety of Nintedanib in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease by Use of Mycophenolate at Baseline: Subgroup Analysis of the SENSCIS Trial
    Highland, Kristin
    Distler, Oliver
    Kuwana, Masataka
    Allanore, Yannick
    Assassi, Shervin
    Azuma, Arata
    Bourdin, Arnaud
    Denton, Christopher
    Distler, Joerg
    Hoffmann-Vold, Anna Maria
    Khanna, Dinesh
    Mayes, Maureen
    Raghu, Ganesh
    Vonk, Madelon
    Gahlemann, Martina
    Girard, Mannaig
    Stowasser, Susanne
    Zoz, Donald
    Fischer, Aryeh
    Maher, Toby
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [38] Efficacy and Safety of Nintedanib in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease by Use of Mycophenolate at Baseline: Subgroup Analysis of the SENSCIS Trial
    Highland, Kristin
    Distler, Oliver
    Kuwana, M.
    Allanore, Yannick
    Assassi, Shervin
    Azuma, Arata
    Bourdin, Arnaud
    Denton, Christopher
    Distler, Joerg
    Hoffmann-Vold, Anna
    Khanna, Dinesh
    Mayes, Maureen
    Raghu, Ganesh
    Vonk, Madelon
    Gahlemann, Martina
    Girard, Mannaig
    Stowasser, Susanne
    Zoz, Donald
    Georgi, Adly
    Maher, Toby
    JOURNAL OF RHEUMATOLOGY, 2020, 47 (07) : 1085 - 1086
  • [39] Treatment for systemic sclerosis-associated interstitial lung disease
    Roofeh, David
    Lescoat, Alain
    Khanna, Dinesh
    CURRENT OPINION IN RHEUMATOLOGY, 2021, 33 (03) : 240 - 248
  • [40] Management of systemic sclerosis-associated interstitial lung disease
    Roofeh, David
    Jaafar, Sara
    Vummidi, Dharshan
    Khanna, Dinesh
    CURRENT OPINION IN RHEUMATOLOGY, 2019, 31 (03) : 241 - 249
12345